isatin sulfonamide 34 [PMID: 11384246] [Ligand Id: 6515] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL439753 |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| Caspase 1/Caspase-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4801] [GtoPdb: 1617] [UniProtKB: P29466] | ||||||||
| ChEMBL | Inhibitory activity against caspase-1 | B | 5.3 | pKi | >5000 | nM | Ki | J Med Chem (2001) 44: 2015-2026 [PMID:11384246] |
| ChEMBL | Inhibitory activity against caspase 1 using Ac-YVAD-AMC substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2005) 48: 7637-7647 [PMID:16302804] |
| ChEMBL | Inhibition of human recombinant caspase 1 assessed as accumulation of 7-amino-4-methylcoumarin substrate | B | 5.3 | pEC50 | >5000 | nM | EC50 | J Med Chem (2008) 51: 8057-8067 [PMID:19049429] |
| Caspase 2/Caspase-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4884] [GtoPdb: 1618] [UniProtKB: P42575] | ||||||||
| ChEMBL | Inhibitory activity against caspase-2 | B | 5.4 | pKi | 4000 | nM | Ki | J Med Chem (2001) 44: 2015-2026 [PMID:11384246] |
| Caspase 3/Caspase-3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2334] [GtoPdb: 1619] [UniProtKB: P42574] | ||||||||
| ChEMBL | Inhibitory activity against caspase-3 | B | 8.92 | pKi | 1.2 | nM | Ki | J Med Chem (2001) 44: 2015-2026 [PMID:11384246] |
| ChEMBL | Inhibition of human recombinant caspase 3 assessed as accumulation of fluorogenic product by fluorometric assay | B | 7.84 | pIC50 | 14.5 | nM | IC50 | J Med Chem (2009) 52: 2188-2191 [PMID:19326941] |
| ChEMBL | Inhibition of caspase3 | B | 7.91 | pIC50 | 12.3 | nM | IC50 | Bioorg Med Chem (2012) 20: 5410-5415 [PMID:22503362] |
| ChEMBL | Inhibitory activity against caspase 3 using Ac-DEVD-AMC substrate | B | 7.91 | pIC50 | 12.2 | nM | IC50 | J Med Chem (2005) 48: 7637-7647 [PMID:16302804] |
| ChEMBL | Inhibition of recombinant human caspase-3 | B | 8.6 | pIC50 | 2.5 | nM | IC50 | J Med Chem (2001) 44: 2015-2026 [PMID:11384246] |
| ChEMBL | Inhibition of staurosporine induced activation of caspase 3 activation in human Hela cells assessed as hydrolysis of Z-DEVD-R110 substrate by microplate fluorescence assay | B | 5.44 | pEC50 | 3670 | nM | EC50 | Bioorg Med Chem Lett (2011) 21: 2192-2197 [PMID:21441025] |
| ChEMBL | Inhibition of human recombinant caspase 3 assessed as accumulation of 7-amino-4-methylcoumarin substrate | B | 7.38 | pEC50 | 41.8 | nM | EC50 | J Med Chem (2008) 51: 8057-8067 [PMID:19049429] |
| Caspase 4/Caspase-4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2226] [GtoPdb: 1620] [UniProtKB: P49662] | ||||||||
| ChEMBL | Inhibitory activity against caspase-4 | B | 5.3 | pKi | >5000 | nM | Ki | J Med Chem (2001) 44: 2015-2026 [PMID:11384246] |
| Caspase 6/Caspase-6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3308] [GtoPdb: 1622] [UniProtKB: P55212] | ||||||||
| ChEMBL | Inhibitory activity against Caspase-6 | B | 5.3 | pKi | >5000 | nM | Ki | J Med Chem (2001) 44: 2015-2026 [PMID:11384246] |
| ChEMBL | Inhibitory activity against caspase 6 using Ac-VEID-AMC substrate | B | 5.3 | pIC50 | >5000 | nM | IC50 | J Med Chem (2005) 48: 7637-7647 [PMID:16302804] |
| ChEMBL | Inhibition of human recombinant caspase 6 assessed as accumulation of fluorogenic product by fluorometric assay | B | 5.3 | pIC50 | >5000 | nM | IC50 | J Med Chem (2009) 52: 2188-2191 [PMID:19326941] |
| ChEMBL | Inhibition of human recombinant caspase 6 assessed as accumulation of 7-amino-4-methylcoumarin substrate | B | 5.3 | pEC50 | >5000 | nM | EC50 | J Med Chem (2008) 51: 8057-8067 [PMID:19049429] |
| Caspase 7/Caspase-7 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3468] [GtoPdb: 1623] [UniProtKB: P55210] | ||||||||
| GtoPdb | - | - | 8.2 | pKi | 6 | nM | Ki | J Med Chem (2001) 44: 2015-26 [PMID:11384246] |
| ChEMBL | Inhibitory activity against Caspase-7 | B | 8.22 | pKi | 6 | nM | Ki | J Med Chem (2001) 44: 2015-2026 [PMID:11384246] |
| ChEMBL | Inhibitory activity against caspase 7 using Ac-DEVD-AMC substrate | B | 7.55 | pIC50 | 28 | nM | IC50 | J Med Chem (2005) 48: 7637-7647 [PMID:16302804] |
| ChEMBL | Inhibition of human recombinant caspase 7 assessed as accumulation of 7-amino-4-methylcoumarin substrate | B | 7.53 | pEC50 | 29.4 | nM | EC50 | J Med Chem (2008) 51: 8057-8067 [PMID:19049429] |
| Caspase 8/Caspase-8 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3776] [GtoPdb: 1624] [UniProtKB: Q14790] | ||||||||
| ChEMBL | Inhibitory activity against Caspase-8 | B | 5.3 | pKi | >5000 | nM | Ki | J Med Chem (2001) 44: 2015-2026 [PMID:11384246] |
| ChEMBL | Inhibitory activity against caspase 8 using Ac-IETD-AMC substrate | B | 4.3 | pIC50 | >50000 | nM | IC50 | J Med Chem (2005) 48: 7637-7647 [PMID:16302804] |
| ChEMBL | Inhibition of human recombinant caspase 8 assessed as accumulation of 7-amino-4-methylcoumarin substrate | B | 5.3 | pEC50 | >5000 | nM | EC50 | J Med Chem (2008) 51: 8057-8067 [PMID:19049429] |
| Caspase 9/Caspase-9 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2273] [GtoPdb: 1625] [UniProtKB: P55211] | ||||||||
| GtoPdb | - | - | 6.92 | pKi | 120 | nM | Ki | J Med Chem (2001) 44: 2015-26 [PMID:11384246] |
| ChEMBL | Inhibitory activity against Caspase-9 | B | 6.92 | pKi | 120 | nM | Ki | J Med Chem (2001) 44: 2015-2026 [PMID:11384246] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]
